Latest news

Stay up to date

Receive updates on new technology developments, market and industry trends, special events, Mayo Clinic technologies available for licensing, and more.

Mass Device | August 1, 2022

EXCERPT: Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.


Med City News | July 15, 2022

EXCERPT: Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.


Mass Devices  | May 24, 2022

EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.


Star Tribune  | May 17, 2022

EXCERPT: The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer


Mayo Clinic News Network | May 2, 2022

EXCERPT: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.


PR Newswire  | January 19, 2022

EXCERPT: Pathogenomix, Inc. collaborated with Mayo Clinic on the development of the techniques and data which supported the application for this FDA Breakthrough Device Designation. 


Star Tribune  | December 23, 2021

EXCERPT: “We anticipate that we’ll have relationship with pretty much every company in Two Discovery Square,” said Dr. Clark Otley, medical director of the Department of Business Development at Mayo Clinic. 


1 6 7 8 9 10